Patrick Donnelly
Stock Analyst at Citigroup
(5.00)
# 12
Out of 4,876 analysts
329
Total ratings
49.71%
Success rate
162.21%
Average return
Main Sectors:
Stocks Rated by Patrick Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Downgrades: Neutral | $50 → $40 | $42.18 | -5.17% | 16 | May 22, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Buy | $400 → $350 | $243.47 | +43.75% | 15 | May 2, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Buy | $400 → $350 | $242.60 | +44.27% | 15 | May 2, 2025 | |
| ILMN Illumina | Maintains: Neutral | $90 → $85 | $94.16 | -9.73% | 16 | Apr 7, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $290 → $215 | $146.75 | +46.51% | 9 | Apr 7, 2025 | |
| MTD Mettler-Toledo International | Upgrades: Buy | $1,400 | $1,193.31 | +17.32% | 13 | Apr 7, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $20 → $15 | $11.70 | +28.21% | 12 | Mar 4, 2025 | |
| AVTR Avantor | Maintains: Neutral | $22 → $18 | $13.74 | +31.00% | 8 | Mar 4, 2025 | |
| TECH Bio-Techne | Maintains: Neutral | $80 → $70 | $52.80 | +32.58% | 11 | Mar 4, 2025 | |
| HOLX Hologic | Maintains: Neutral | $80 → $70 | $65.11 | +7.51% | 14 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $225 → $210 | $158.16 | +32.78% | 10 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $650 → $570 | $412.12 | +38.31% | 19 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $185 | $177.06 | +4.48% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $155 → $175 | $151.59 | +15.44% | 20 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $265 | $201.46 | +31.54% | 12 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $23 | $5.20 | +342.31% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $44 → $50 | $28.70 | +74.22% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $20 | $11.36 | +76.06% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $51.81 | +44.76% | 13 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $119.42 | +38.17% | 26 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $45 | $50.03 | -10.05% | 9 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $28 | $25.09 | +11.60% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $145 | $98.79 | +46.78% | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $62 | $48.04 | +28.64% | 13 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $265 → $300 | $354.91 | -15.47% | 24 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $3.03 | +197.52% | 6 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.75 → $2.75 | $1.98 | +38.89% | 4 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $250 → $260 | $256.98 | +1.18% | 11 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $6.37 | -5.81% | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $28 → $32 | $5.33 | +500.38% | 2 | Nov 30, 2018 |
Bruker
May 22, 2025
Downgrades: Neutral
Price Target: $50 → $40
Current: $42.18
Upside: -5.17%
Bio-Rad Laboratories
May 2, 2025
Maintains: Buy
Price Target: $400 → $350
Current: $243.47
Upside: +43.75%
Bio-Rad Laboratories
May 2, 2025
Maintains: Buy
Price Target: $400 → $350
Current: $242.60
Upside: +44.27%
Illumina
Apr 7, 2025
Maintains: Neutral
Price Target: $90 → $85
Current: $94.16
Upside: -9.73%
ICON Public Limited Company
Apr 7, 2025
Maintains: Buy
Price Target: $290 → $215
Current: $146.75
Upside: +46.51%
Mettler-Toledo International
Apr 7, 2025
Upgrades: Buy
Price Target: $1,400
Current: $1,193.31
Upside: +17.32%
10x Genomics
Mar 4, 2025
Maintains: Buy
Price Target: $20 → $15
Current: $11.70
Upside: +28.21%
Avantor
Mar 4, 2025
Maintains: Neutral
Price Target: $22 → $18
Current: $13.74
Upside: +31.00%
Bio-Techne
Mar 4, 2025
Maintains: Neutral
Price Target: $80 → $70
Current: $52.80
Upside: +32.58%
Hologic
Mar 4, 2025
Maintains: Neutral
Price Target: $80 → $70
Current: $65.11
Upside: +7.51%
Mar 4, 2025
Maintains: Neutral
Price Target: $225 → $210
Current: $158.16
Upside: +32.78%
Mar 4, 2025
Maintains: Neutral
Price Target: $650 → $570
Current: $412.12
Upside: +38.31%
Mar 4, 2025
Downgrades: Neutral
Price Target: $185
Current: $177.06
Upside: +4.48%
Mar 4, 2025
Upgrades: Neutral
Price Target: $155 → $175
Current: $151.59
Upside: +15.44%
Jan 30, 2025
Maintains: Buy
Price Target: $285 → $265
Current: $201.46
Upside: +31.54%
Dec 11, 2024
Downgrades: Neutral
Price Target: $30 → $23
Current: $5.20
Upside: +342.31%
Dec 11, 2024
Upgrades: Buy
Price Target: $44 → $50
Current: $28.70
Upside: +74.22%
Nov 6, 2024
Maintains: Buy
Price Target: $18 → $20
Current: $11.36
Upside: +76.06%
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $75
Current: $51.81
Upside: +44.76%
Aug 22, 2024
Maintains: Buy
Price Target: $150 → $165
Current: $119.42
Upside: +38.17%
Aug 8, 2024
Maintains: Buy
Price Target: $40 → $45
Current: $50.03
Upside: -10.05%
Aug 7, 2024
Maintains: Buy
Price Target: $30 → $28
Current: $25.09
Upside: +11.60%
Jul 30, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $98.79
Upside: +46.78%
Feb 8, 2024
Maintains: Buy
Price Target: $64 → $62
Current: $48.04
Upside: +28.64%
Dec 11, 2023
Maintains: Neutral
Price Target: $265 → $300
Current: $354.91
Upside: -15.47%
Dec 11, 2023
Maintains: Buy
Price Target: $7 → $9
Current: $3.03
Upside: +197.52%
Aug 10, 2023
Maintains: Neutral
Price Target: $3.75 → $2.75
Current: $1.98
Upside: +38.89%
Feb 17, 2023
Maintains: Neutral
Price Target: $250 → $260
Current: $256.98
Upside: +1.18%
Nov 3, 2022
Maintains: Buy
Price Target: $8 → $6
Current: $6.37
Upside: -5.81%
Nov 30, 2018
Upgrades: Neutral
Price Target: $28 → $32
Current: $5.33
Upside: +500.38%